Operates as an impact operator, publishing metrics-driven impact reports, embedding racial and social equity in governance, and prioritizing founders from underserved learner communities across learning, workforce, justice, and health. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Rockies-rooted, research-heavy investor using a Michael Porter–inspired Build x Enable x Secure framework, intensive diligence (three meetings, customer interviews, IC presentation) and 100+ years' operating experience plus expert network. The firm continues to build its presence across the venture capital landscape.
Offers strictly non-dilutive term loans without warrants, tailored to B2B SaaS businesses in the $1M to $10M ARR range. The firm prioritizes capital-efficient, niche vertical SaaS companies and openly shares its revenue-financing frameworks and underwriting methodologies.
Crypto-native operators who architect token-first ecosystems via token design, governance, and collective bootstrapping, empowering founders construct enduring token economies from day one and backing 100+ on-chain projects.
Digital security-focused, operator-led firm that co-founds and incubates formative-stage companies alongside world-class technologists, presenting hands-on founder support from leaders who've built flagship security companies.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
